According to the QuintilesIMS Institute’s 2017 Medicine Use and Spending report, Truvada had $3.1 billion in sales on an invoice price basis in 2016, ranking 17th among the top 20 medicines in the U.S. based on invoice spending.
In the first video dispatch from the National Association of Chain Drug Stores Annual Meeting, Drug Store News talks to Innovation’s Doyle Jensen about how the company is looking to use automation to improve patient care in the pharmacy.
Procter & Gamble is holding talks with Trian Fund Management, which has a $3.5 billion stake in the company, about the future of its brands, the P&G CEO David Taylor confirmed to CNBC. Taylor called the talks “constructive” and noted, "We are willing to engage. We want to be better.” Trian has been increasing its stake in P&G and the company looks to cut costs by some $10 billion, the report said. (CNBC)
The National Community Pharmacists Association has sent its comments on to the Centers for Medicare and Medicaid Services regarding the agency’s recently proposed changes to how direct and indirect remuneration fees are reported.
Since 2011, 68 novel therapies have been approved globally across 22 cancer indications. The QunitilesIMS Institute report looks at what technological advances and development trends have made this possible, as well as their cost.
Under the acquisition, MedCart will continue to operate as it did before, but as a new business unit under Albertsons’ pharmacy team structure, with the leadership team reporting directly to Albertsons group VP pharmacy operations, Dain Rusik.